Narang Biotec Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.50 Cr
- Satisfied Charges ₹ 8.43 Cr
- Revenue Growth 28.06%
- Profit Growth 20.97%
- Ebitda 705.48%
- Net Worth 31.24%
- Total Assets 0.97%
About Narang Biotec
Narang Biotec Private Limited (NBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 30 March 2012 and has a history of 12 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹9.50 Cr. The company has closed loans amounting to ₹8.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rakesh Narang, Anuj Narang, and Sushma Narang serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100DL2012PTC233785
-
Company No.
233785
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
30 Mar 2012
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Narang Biotec?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Narang
|
Director | 30-Mar-2012 | Current |
|
Anuj Narang
|
Director | 30-Mar-2012 | Current |
|
Sushma Narang
|
Director | 21-May-2012 | Current |
Financial Performance of Narang Biotec.
Narang Biotec Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.06% increase. The company also saw a substantial improvement in profitability, with a 20.97% increase in profit. The company's net worth Soared by an impressive increase of 31.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Narang Biotec?
In 2023, Narang Biotec had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹95.00 M
₹84.30 M
Charges Breakdown by Lending Institutions
- Others : 9.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Nov 2018 | Others | ₹9.50 Cr | Open |
| 02 Feb 2022 | Others | ₹1.95 Cr | Satisfied |
| 27 Jul 2020 | Others | ₹6.60 M | Satisfied |
| 30 Apr 2018 | Others | ₹4.34 Cr | Satisfied |
| 29 Dec 2012 | Corporation Bank | ₹1.48 Cr | Satisfied |
How Many Employees Work at Narang Biotec?
Unlock and access historical data on people associated with Narang Biotec, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Narang Biotec, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Narang Biotec's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.